Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 18 Source: CRO
- €37.5 million turnover
-
€25,600
profit
-
31st Dec 17 Source: CRO
- €72.7 million turnover
-
€37,763
profit
- 7 more years available »
Ranking
By Turnover
(€37.5 million)- 753rd in Top Companies
- 74th in Pharma
-
- €37.5 million
Employees
- David Cadogan Vice President}
Latest News
- 1:33pm WeWork on track for profits and positive cash flow in 2021, says chairman
- 1:33pm WeWork on track for profits in 2021, says chairman
- 12:10pm Varadkar to meet banks in row over interest on mortgage payment breaks
- Jul 11 AIB to compensate another 1,100 tracker mortgage holders
- Jul 11 New Powerscourt Springs hotel to open in defiance of virus gloom